IDEXX LABORATORIES INC /DE Line of Credit, Current
IDEXX LABORATORIES INC /DE (IDXX) had Line of Credit, Current of $519.00 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2026-08-04
- 2026-06-30: Line of Credit, Current $519.00M.
- 2026-03-31: Line of Credit, Current $530.00M.
- 2025-12-31: Line of Credit, Current $398.00M.
- 2025-09-30: Line of Credit, Current $455.00M.
| Period end | Line of Credit, Current | Line of Credit, Current as first filed |
|---|---|---|
| 2026-06-30 | $519.00M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $530.00M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $398.00M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $455.00M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $579.00M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $319.50M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $250.00M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $250.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $250.00M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $250.00M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $250.00M 10-K · filed 2025-02-21 | |
| 2023-09-30 | $250.00M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $264.00M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $431.50M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $250.00M 10-Q · filed 2024-05-01 | $579.00M 10-K · filed 2023-02-16 |
| 2022-09-30 | $633.00M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $611.00M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $400.00M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $73.50M 10-K · filed 2023-02-16 | |
| 2020-12-31 | $0.00 10-K · filed 2022-02-16 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $121.60M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $486.82M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $288.76M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $229.50M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $251.53M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $347.00M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $398.94M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $414.50M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $437.00M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $407.50M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $655.00M 10-K · filed 2019-02-15 | |
| 2017-09-30 | $686.25M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $704.00M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $671.00M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $611.00M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $488.00M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $558.00M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $622.00M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $573.00M 10-K · filed 2017-02-17 | |
| 2015-09-30 | $542.50M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | $498.00M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $549.50M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $549.00M 10-K · filed 2016-02-17 | |
| 2014-09-30 | $375.00M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $384.00M 10-Q · filed 2014-07-25 | |
| 2014-03-31 | $315.00M 10-Q · filed 2014-04-25 | |
| 2013-12-31 | $277.00M 10-K · filed 2015-02-17 | |
| 2013-09-30 | $397.20M 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $367.50M 10-Q · filed 2013-07-23 | |
| 2013-03-31 | $260.00M 10-Q · filed 2013-04-23 | |
| 2012-12-31 | $212.00M 10-K · filed 2014-02-18 | |
| 2012-09-30 | $232.00M 10-Q · filed 2012-10-19 | |
| 2012-06-30 | $244.00M 10-Q · filed 2012-07-20 | |
| 2012-03-31 | $254.00M 10-Q · filed 2012-04-20 | |
| 2011-12-31 | $243.00M 10-K · filed 2013-02-19 | |
| 2011-09-30 | $154.00M 10-Q · filed 2011-10-21 | |
| 2011-06-30 | $132.55M 10-Q · filed 2011-07-22 | |
| 2011-03-31 | $126.59M 10-Q · filed 2011-04-21 | |
| 2010-12-31 | $129.00M 10-K · filed 2012-02-17 | |
| 2010-09-30 | $125.91M 10-Q · filed 2010-10-22 | |
| 2010-06-30 | $133.86M 10-Q · filed 2010-07-23 | |
| 2009-12-31 | $118.79M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |